Life Sciences Expansion Fund update
The program guide, application instructions, and contact page were revised with new eligibility, scope, and funding details.
See more
The program guide now shows new and expanded eligibility and scope rules, including a five million dollar sales threshold for financial statements, a technology maturity requirement of NMT 7 or higher, and a clearer phase two focus on AI-enabled and other innovative health technologies. It also adds or tightens funding and cost rules, including support of up to 33% of eligible project costs to a maximum of 2.5 million dollars, combined government funding up to 67%, and updated notes on foreign-currency quotes and project review conditions. The application process section was also updated to add detailed financial-statement requirements by revenue band and to require foreign-currency quote amounts to be converted to CAD at the Bank of Canada exchange rate on the transaction date. The contact page for the program was reduced to a much less usable support view, changing how applicants can reach the program and submit questions.

